REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 79 filers reported holding REVANCE THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.25 and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,984,228 | -12.3% | 78,397 | +11.6% | 0.01% | -12.5% |
| Q1 2023 | $2,261,818 | +19.9% | 70,221 | -31.3% | 0.01% | +14.3% |
| Q4 2022 | $1,886,760 | -40.7% | 102,208 | -13.3% | 0.01% | -46.2% |
| Q3 2022 | $3,183,000 | -18.4% | 117,907 | -41.1% | 0.01% | +8.3% |
| Q1 2022 | $3,902,000 | +37.8% | 200,094 | +96.9% | 0.01% | +33.3% |
| Q3 2021 | $2,831,000 | +8.8% | 101,615 | +15.8% | 0.01% | 0.0% |
| Q2 2021 | $2,601,000 | +12.0% | 87,763 | +5.6% | 0.01% | +12.5% |
| Q1 2021 | $2,322,000 | -1.4% | 83,091 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $2,355,000 | +15.7% | 83,091 | +2.6% | 0.01% | 0.0% |
| Q3 2020 | $2,036,000 | -11.4% | 80,998 | -13.9% | 0.01% | -20.0% |
| Q2 2020 | $2,298,000 | +581.9% | 94,102 | +261.9% | 0.01% | +900.0% |
| Q2 2019 | $337,000 | -17.8% | 26,000 | 0.0% | 0.00% | -50.0% |
| Q1 2019 | $410,000 | -21.6% | 26,000 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $523,000 | -19.0% | 26,000 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $646,000 | -9.5% | 26,000 | 0.0% | 0.00% | -33.3% |
| Q2 2018 | $714,000 | -10.9% | 26,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $801,000 | -13.9% | 26,000 | 0.0% | 0.00% | -25.0% |
| Q4 2017 | $930,000 | +29.9% | 26,000 | 0.0% | 0.00% | +33.3% |
| Q3 2017 | $716,000 | +4.4% | 26,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $686,000 | +26.8% | 26,000 | 0.0% | 0.00% | +50.0% |
| Q1 2017 | $541,000 | +0.6% | 26,000 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $538,000 | +27.8% | 26,000 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $421,000 | +18.9% | 26,000 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $354,000 | -22.0% | 26,000 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $454,000 | -74.4% | 26,000 | -50.0% | 0.00% | -50.0% |
| Q4 2015 | $1,776,000 | +129.5% | 52,000 | +100.0% | 0.00% | +33.3% |
| Q3 2015 | $774,000 | -6.9% | 26,000 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $831,000 | +54.2% | 26,000 | 0.0% | 0.00% | +50.0% |
| Q1 2015 | $539,000 | +22.5% | 26,000 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $440,000 | -12.5% | 26,000 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $503,000 | -43.1% | 26,000 | 0.0% | 0.00% | -50.0% |
| Q2 2014 | $884,000 | – | 26,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $52,671,000 | 26.22% |
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $24,561,000 | 22.85% |
| Sio Capital Management, LLC | 254,581 | $4,012,000 | 1.08% |
| ArrowMark Colorado Holdings LLC | 3,409,217 | $53,729,000 | 0.51% |
| Fosun International Ltd | 472,532 | $7,447,000 | 0.47% |
| Rhenman & Partners Asset Management AB | 193,181 | $3,045,000 | 0.36% |
| Phoenix Investment Adviser LLC | 4,900 | $77,000 | 0.17% |
| HARBOURVEST PARTNERS LLC | 26,565 | $419,000 | 0.15% |
| Quinn Opportunity Partners LLC | 56,672 | $893,000 | 0.12% |
| MFN Partners Management, LP | 46,000 | $725,000 | 0.12% |